Improved Methods Of Assessing Uch-L1 Status In Patient Samples - EP3519824

The patent EP3519824 was granted to Abbott on Nov 20, 2024. The application was originally filed on Oct 2, 2017 under application number EP17791223A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3519824

ABBOTT
Application Number
EP17791223A
Filing Date
Oct 2, 2017
Status
Granted And Under Opposition
Oct 18, 2024
Grant Date
Nov 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

OXONAug 20, 2025ADMISSIBLE

Patent Citations (137) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20070697835-
DESCRIPTIONUS20080142048-
DESCRIPTIONEP0404097
DESCRIPTIONUS2003170881
DESCRIPTIONUS2003186374
DESCRIPTIONUS2004018577
DESCRIPTIONUS2005054078
DESCRIPTIONUS2006134713
DESCRIPTIONUS2006160164
DESCRIPTIONUS4554101
DESCRIPTIONUS4704692
DESCRIPTIONUS4816567
DESCRIPTIONUS4873316
DESCRIPTIONUS4946778
DESCRIPTIONUS5006309
DESCRIPTIONUS5063081
DESCRIPTIONUS5089424
DESCRIPTIONUS5223409
DESCRIPTIONUS5225539
DESCRIPTIONUS5241070
DESCRIPTIONUS5258498
DESCRIPTIONUS5294404
DESCRIPTIONUS5304489
DESCRIPTIONUS5352803
DESCRIPTIONUS5359093
DESCRIPTIONUS5403484
DESCRIPTIONUS5427908
DESCRIPTIONUS5468646
DESCRIPTIONUS5480792
DESCRIPTIONUS5496925
DESCRIPTIONUS5516637
DESCRIPTIONUS5525524
DESCRIPTIONUS5530101
DESCRIPTIONUS5543524
DESCRIPTIONUS5565362
DESCRIPTIONUS5571698
DESCRIPTIONUS5573904
DESCRIPTIONUS5580717
DESCRIPTIONUS5585089
DESCRIPTIONUS5593896
DESCRIPTIONUS5627052
DESCRIPTIONUS5658727
DESCRIPTIONUS5679526
DESCRIPTIONUS5693762
DESCRIPTIONUS5698426
DESCRIPTIONUS5714352
DESCRIPTIONUS5723323
DESCRIPTIONUS5733743
DESCRIPTIONUS5750753
DESCRIPTIONUS5763192
DESCRIPTIONUS5766886
DESCRIPTIONUS5770429
DESCRIPTIONUS5780225
DESCRIPTIONUS5783699
DESCRIPTIONUS5814476
DESCRIPTIONUS5817483
DESCRIPTIONUS5821047
DESCRIPTIONUS5824514
DESCRIPTIONUS5824799
DESCRIPTIONUS5827690
DESCRIPTIONUS5833985
DESCRIPTIONUS5837243
DESCRIPTIONUS5849992
DESCRIPTIONUS5851776
DESCRIPTIONUS5885527
DESCRIPTIONUS5916771
DESCRIPTIONUS5922615
DESCRIPTIONUS5922845
DESCRIPTIONUS5939272
DESCRIPTIONUS5939598
DESCRIPTIONUS5947124
DESCRIPTIONUS5969108
DESCRIPTIONUS5976862
DESCRIPTIONUS5985579
DESCRIPTIONUS5985615
DESCRIPTIONUS5994616
DESCRIPTIONUS5998209
DESCRIPTIONUS6017517
DESCRIPTIONUS6019944
DESCRIPTIONUS6075181
DESCRIPTIONUS6091001
DESCRIPTIONUS6096311
DESCRIPTIONUS6111166
DESCRIPTIONUS6113855
DESCRIPTIONUS6114598
DESCRIPTIONUS6130364
DESCRIPTIONUS6143576
DESCRIPTIONUS6180370
DESCRIPTIONUS6204023
DESCRIPTIONUS6270765
DESCRIPTIONUS6303755
DESCRIPTIONUS6365116
DESCRIPTIONUS6410690
DESCRIPTIONUS6632926
DESCRIPTIONUS6682928
DESCRIPTIONUS6699658
DESCRIPTIONUS6914128
DESCRIPTIONUS6984720
DESCRIPTIONUS7612181
DESCRIPTIONWO0009560
DESCRIPTIONWO0037504
DESCRIPTIONWO0056772
DESCRIPTIONWO0158956
DESCRIPTIONWO0202773
DESCRIPTIONWO2007024715
DESCRIPTIONWO2016161400
DESCRIPTIONWO2016161402
DESCRIPTIONWO9002809
DESCRIPTIONWO9110737
DESCRIPTIONWO9110741
DESCRIPTIONWO9117271
DESCRIPTIONWO9201047
DESCRIPTIONWO9202551
DESCRIPTIONWO9209690
DESCRIPTIONWO9215679
DESCRIPTIONWO9218619
DESCRIPTIONWO9220791
DESCRIPTIONWO9222324
DESCRIPTIONWO9301288
DESCRIPTIONWO9311161
DESCRIPTIONWO9311236
DESCRIPTIONWO9402602
DESCRIPTIONWO9515982
DESCRIPTIONWO9520401
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9729131
DESCRIPTIONWO9816654
DESCRIPTIONWO9824893
DESCRIPTIONWO9831700
DESCRIPTIONWO9850433
DESCRIPTIONWO9945031
DESCRIPTIONWO9953049
INTERNATIONAL-SEARCH-REPORTUS2014303041
INTERNATIONAL-SEARCH-REPORTWO2014194329
INTERNATIONAL-SEARCH-REPORTWO2015157300
OPPOSITIONWO2010019553

Non-Patent Literature (NPL) Citations (103) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ADAMCZYK et al., Anal. Chim. Acta, (20060000), vol. 579, no. 1, pages 61 - 67-
DESCRIPTION- ADAMCZYK et al., Bioconjugate Chem., (20000000), vol. 11, pages 714 - 724-
DESCRIPTION- ADAMCZYK et al., Bioorg. Med. Chem. Lett., (20040000), vol. 4, pages 2313 - 2317-
DESCRIPTION- ADAMCZYK et al., Bioorg. Med. Chem. Lett., (20060000), vol. 16, pages 1324 - 1328-
DESCRIPTION- ADAMCZYK et al., Biorg. Med. Chem. Lett., (20040000), vol. 14, pages 3917 - 3921-
DESCRIPTION- ADAMCZYK et al., J. Org. Chem., (19980000), vol. 63, pages 5636 - 5639-
DESCRIPTION- ADAMCZYK et al., Org. Lett., (19990000), vol. 1, pages 779 - 781-
DESCRIPTION- ADAMCZYK et al., Org. Lett., (20030000), vol. 5, pages 3779 - 3782-
DESCRIPTION- ADAMCZYK et al., Tetrahedron, (19990000), vol. 55, pages 10899 - 10914-
DESCRIPTION- AMES et al., J. Immunol. Methods, (19950000), vol. 184, pages 177 - 186-
DESCRIPTION- BABCOOK et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, pages 7843 - 7848-
DESCRIPTION- BARBAS et al., Proc. Nat. Acad. Sci. USA, (19940000), vol. 91, pages 3809 - 3813-
DESCRIPTION- BARBAS et al., Proc. Natl. Acad. Sci. USA, (19910000), vol. 88, pages 7978 - 7982-
DESCRIPTION- BETTER et al., Science, (19880000), vol. 240, pages 1041 - 1043-
DESCRIPTION- BIRD et al., Science, (19880000), vol. 242, pages 423 - 426-
DESCRIPTION- BRINKMANN et al., J. Immunol. Methods, (19950000), vol. 182, pages 41 - 50-
DESCRIPTION- BURTON et al., Advances in Immunology, (19940000), vol. 57, pages 191 - 280-
DESCRIPTION- CHOTHIA et al., Nature, (19890000), vol. 342, pages 877 - 883-
DESCRIPTION- CHOTHIA; LESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917-
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628-
DESCRIPTION- CONRAD et al., PlantMol. Biol., (19980000), vol. 38, pages 101 - 109-
DESCRIPTION- CRAMER et al., Curr. Top. Microbiol. Immunol., (19990000), vol. 240, pages 95 - 118-
DESCRIPTION- EREN et al., Immunol., (19980000), vol. 93, pages 154 - 161-
DESCRIPTION- Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition. (NCCLS document EP5-A2), (20040000), ISBN 1-56238-542-9-
DESCRIPTION- Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline ( NCCLS document EP6-A), NCCLS, (20030000), ISBN 1-56238-498-8-
DESCRIPTION- FUCHS et al., Bio/Technology, (19910000), vol. 9, pages 1369 - 1372-
DESCRIPTION- FUNARO et al., BMC Biotechnology, (20080000), no. 8, page 85-
DESCRIPTION- GARRARD et al., BiolTechnology, (19910000), vol. 9, pages 1373 - 1377-
DESCRIPTION- GRAM et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 3576 - 3580-
DESCRIPTION- GRAY et al., J. Imm. Meth., (19950000), vol. 182, pages 155 - 163-
DESCRIPTION- GREEN et al., Nature Genetics, (19940000), vol. 7, pages 13 - 21-
DESCRIPTION- GREEN; JAKOBOVITS, J. Exp. Med., (19980000), vol. 188, pages 483 - 495-
DESCRIPTION- GRIFFITHS et al., EMBO J., (19930000), vol. 12, pages 725 - 734-
DESCRIPTION- HANES et al., Proc. Natl. Acad. Sci. USA, (19970000), vol. 94, pages 4937 - 4942-
DESCRIPTION- HANES et al., Proc. Natl. Acad. Sci. USA, (19980000), vol. 95, pages 14130 - 14135-
DESCRIPTION- HAWKINS et al., J. Mol. Biol., (19920000), vol. 226, pages 889 - 896-
DESCRIPTION- HAY et al., Hum. Antibod. Hybridomas, (19920000), vol. 3, pages 81 - 85-
DESCRIPTION- HOLLIGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, no. 14, pages 6444 - 6448-
DESCRIPTION- HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOLT et al., Trends in Biotechnology, (20140000), vol. 21, pages 484 - 490-
DESCRIPTION- HOOD et al., Adv. Exp. Med. Biol., (19990000), vol. 464, pages 127 - 147-
DESCRIPTION- HOOGENBOOM et al., Nucl. Acids Res., (19910000), vol. 19, pages 4133 - 4137-
DESCRIPTION- HUSE et al., Science, (19890000), vol. 246, pages 1275 - 1281-
DESCRIPTION- HUSTON et al., Methods in Enzymology, (19910000), vol. 203, pages 46 - 88-
DESCRIPTION- HUSTON et al., PNAS USA, (19880000), vol. 85, pages 5879 - 5883-
DESCRIPTION- Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition. CLSI document EP7-A2, Clinical and Laboratory Standards Institute, (20050000), ISBN 1-56238-584-4-
DESCRIPTION- JACKSON et al., J. Immunol., (19950000), vol. 154, no. 7, pages 3310 - 3319-
DESCRIPTION- JAMES F. PIERSON-PERRY et al., Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline, Clinical and Laboratory Standards Institute, (20120601), page 80, ISBN 1562387952-
DESCRIPTION- KAUFMAN; SHARP, J. Mol. Biol., (19820000), vol. 159, pages 601 - 621-
DESCRIPTION- KENNY et al., Bio/Technol., (19950000), vol. 13, pages 787 - 790-
DESCRIPTION- KETTLEBOROUGH et al., Eur. J. Immunol., (19940000), vol. 24, pages 952 - 958-
DESCRIPTION- KYTE et al., J. Mol. Biol., (19820000), vol. 157, pages 105 - 132-
DESCRIPTION- MACCALLUM, J. Mol. Biol., (19960000), vol. 262, no. 5, pages 732 - 745-
DESCRIPTION- MARKS et al., BioTechnology, (19920000), vol. 10, pages 779 - 783-
DESCRIPTION- MATTINGLY et al., In Luminescence Biotechnology: Instruments and Applications, CRC Press, (20020000), pages 77 - 105-
DESCRIPTION- MATTINGLY, J. Biolumin. Chemilumin., (19910000), vol. 6, pages 107 - 114-
DESCRIPTION- MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554-
DESCRIPTION- MCCAPRA et al., Photochem. Photobiol., (19650000), vol. 4, pages 1111 - 21-
DESCRIPTION- MENDEZ et al., Nature Genetics, (19970000), vol. 15, pages 146 - 156-
DESCRIPTION- MILSTEIN et al., Nature, (19830000), vol. 305, no. 5934, pages 537 - 540-
DESCRIPTION- MULLINAX et al., BioTechniques, (19920000), vol. 12, no. 6, pages 864 - 869-
DESCRIPTION- NGUYEN et al., Microbiol. Immunol., (19970000), vol. 41, pages 901 - 907-
DESCRIPTION- PADLAN, FASEB J., (19950000), vol. 9, pages 133 - 139-
DESCRIPTION- PERSIC et al., Gene, (19970000), vol. 187, pages 9 - 18-
DESCRIPTION- POWELL et al., Biotechnol., (19900000), vol. 8, pages 333 - 337-
DESCRIPTION- Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, pages 4216 - 4220-
DESCRIPTION- RAZAVI et al., Luminescence, (20000000), vol. 15, pages 239 - 244-
DESCRIPTION- RAZAVI et al., Luminescence, (20000000), vol. 15, pages 245 - 249-
DESCRIPTION- ROBERTS; SZOSTAK, Proc. Natl. Acad. Sci. USA, (19970000), vol. 94, pages 12297 - 12302-
DESCRIPTION- SANDHU et al., Crit. Rev. Biotechnol., (19960000), vol. 16, pages 95 - 118-
DESCRIPTION- SAWAI et al., Am. J. Reprod. Immunol., (19950000), vol. 34, pages 26 - 34-
DESCRIPTION- SCHIER et al., Gene, (19950000), vol. 169, pages 147 - 155-
DESCRIPTION- SHU et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 7995 - 7999-
DESCRIPTION- SKERRA et al., Science, (19880000), vol. 240, pages 1038 - 1041-
DESCRIPTION- STAERZ et al., Nature, (19850000), vol. 314, no. 6012, pages 628 - 631-
DESCRIPTION- STEENBAKKERS et al., Molec. Biol. Reports, (19940000), vol. 19, pages 125 - 134-
DESCRIPTION- URLAUB; CHASIN, Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, pages 4216 - 4220-
DESCRIPTION- User Verification of Performance for Precision and Trueness; Approved Guideline- Second Edition ( CLSI document EP15-A2), Clinical and Laboratory Standards Institute, (20050000), ISBN 1-56238-574-7-
DESCRIPTION- WEN et al., J. Immunol., (19870000), vol. 17, pages 887 - 892-
DESCRIPTION- WU, C. et al., Nature Biotechnology, (20070000), vol. 25, no. 11, pages 1290 - 1297-
DESCRIPTION- WU, C. et al., Nature Biotechnology, (20070000), vol. 25, pages 1290 - 1297-
DESCRIPTION- WU et al., Nature Biotech., (20070000), vol. 25, pages 1290 - 1297-
DESCRIPTION- YELTON et al., J. Immunol., (19950000), vol. 155, pages 1994 - 2004-
DESCRIPTION- ZAPATA et al., Protein Eng., (19950000), vol. 8, no. 10, pages 1057 - 1062-
INTERNATIONAL-SEARCH-REPORT- SONG LINAN ET AL, "DEVELOPMENT OF DIGITAL ELISAS FOR ULTRASENSITIVE MEASUREMENT OF SERUM GLIAL FIBRILLARY ACID PROTEIN AND UBIQUITIN C-TERMINAL HYDROLASE WITH CLINICAL UTILITIES IN HUMAN TRAUMATIC BRAIN INJURY", ALZHEIMER'S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER'SASSOCIATION, (20170718), vol. 13, no. 7, doi:10.1016/J.JALZ.2017.06.1453, ISSN 1552-5260, XP085217220 [XP] 1-4,11-18 * the whole document * [I] 1-40
INTERNATIONAL-SEARCH-REPORT- VIKRAM PUVENNA ET AL, "Significance of Ubiquitin Carboxy-Terminal Hydrolase L1 Elevations in Athletes after Sub-Concussive Head Hits", PLOS ONE, (20140507), vol. 9, no. 5, doi:10.1371/journal.pone.0096296, page e96296, XP055427505 [X] 1-4 * the whole document * [I] 1-10,12,18-34,37,39
OPPOSITION- Anonymous, "EP05-A3 - Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline-Third Edition", Clinical and Laboratory Standards Institute, (20141001), XP093308778-
OPPOSITION- Anonymous, "History of ELISA", Molecular Devices LLC, (20200101), Molecular Devices LLC, URL: https://www.moleculardevices.com/sites/default/files/en/assets/infographics/br/history-of-elisa.pdf, XP093308781-
OPPOSITION- Anonymous, "The i-STAT® System: Comprehensive Point-of-Care Testing aISIA", Abbott, (20120501), XP093308770-
OPPOSITION- Mondello et al., "Blood-based diagnostics of traumatic brain injuries", Expert Rev Mol Diagn., (20110100), vol. 11, no. 1, pages 65 - 78, XP009152467-
OPPOSITION- Shah et al., "Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide", Western Journal of Emergency Medicine, (20100200), vol. XI, no. 1, XP055264883-
OPPOSITION- Kim Tae Kyum, Oh Sang Wook, Hong Soon Cheol, Mok Young Joon, Choi Eui Yul, "Point‐of‐Care Fluorescence Immunoassay for Cardiac Panel Biomarkers", Journal of clinical laboratory, NEW YORK, NY., US, US , (20141101), vol. 28, no. 6, doi:10.1002/jcla.21704, ISSN 0887-8013, pages 419 - 427, XP093308772
OPPOSITION- Sowder et al., "Analytical performance evaluation of the i-STAT Total -human chorionic gonadotropin immunoassay", Clinica Chimica Acta, (2015), vol. 446, doi:10.1016/j.cca.2015.04.025, pages 165 - 170, XP029242905
OPPOSITION- Dupuy et al., "Analytical evaluation of point of care cTnT and clinical performances in an unselected population as compared with central laboratory highly sensitive cTnT", Clinical Biochemistry, (2015), vol. 48, doi:10.1016/j.clinbiochem.2014.09.027, pages 334 - 339, XP029145578
OPPOSITION- Changhong Ren, Firas Kobeissy, Ali Alawieh, Na Li, Ning Li, Kazem Zibara, Susie Zoltewicz, Joy Guingab-Cagmat, Stephen F. Larner, Yuchuan Ding, Ronald L. Hayes, Xunming Ji, Stefania Mondello, "Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients", Scientific Reports, (20160701), vol. 6, no. 1, doi:10.1038/srep24588, XP055454920
OPPOSITION- Buus et al., "High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh-density Peptide Microarrays", Molecular & Cellular Proteomics, (2012), vol. 11, doi:10.1074/mcp.M112.020800, pages 1790 - 1800, XP055247517
OPPOSITION- Ramon Diaz-Arrastia, Wang Kevin K.W., Papa Linda, Sorani Marco D., Yue John K., Puccio Ava M., Mcmahon Paul J., Inoue Tomoo, Yuh Esther L., Lingsma Hester F., Maas Andrew I.R., Valadka Alex B., Okonkwo David O., Manley And The Track-Tbi Investigat Geoffrey T., Casey Including Scott S., Cheong Maxwell, Cooper Shelly R., Dams-O'connor Kristen, Gordon Wayne A., Hricik Allison J., Menon David K., Mukherjee Pratik, Schnyer David M., Sinha Tuhin K., Vassar Mary J., "Acute Biomarkers of Traumatic Brain Injury: Relationship between Plasma Levels of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein", JOURNAL OF NEUROTRAUMA., M.A. LIEBERT, NEW YORK, NY., US, US , (20140101), vol. 31, no. 1, doi:10.1089/neu.2013.3040, ISSN 0897-7151, pages 19 - 25, XP055455067
OPPOSITION- Papa Linda, Akinyi Linnet, Liu Ming Cheng, Pineda Jose A., Tepas Joseph J., Oli Monika W., Zheng Wenrong, Robinson Gillian, Robicsek Steven A., Gabrielli Andrea, Heaton Shelley C., Hannay H Julia, Demery Jason A., Brophy Gretchen M., Layon Joe, Robertson Claudia S., Hayes Ronald L., Wang Kevin K. W., "Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury* : ", Critical Care Medicine, Lippincott Williams & Wilkins, (20100101), vol. 38, no. 1, doi:10.1097/CCM.0b013e3181b788ab, ISSN 0090-3493, pages 138 - 144, XP093308765
OPPOSITION- Papa Linda; Lewis Lawrence M; Silvestri Salvatore; Falk Jay L; Giordano Philip; Brophy Gretchen M; Demery Jason A; Liu Ming Cheng; Mo Jixiang; Akinyi Linnet; Mondello Stefania; Schmid Kara; Robertson Claudia S; Tortella Frank C; Hayes Ronald L; Wang Kevin K W, "Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.", Journal of Trauma and Acute Care Surgery, Hagerstown, Md : Wolters Kluwer, Lippincott Williams & Wilkins, US, US , (20120501), vol. 72, no. 5, doi:10.1097/TA.0b013e3182491e3d, ISSN 2163-0755, pages 1335 - 1344, XP009192666
OPPOSITION- Papa et al., "Performance of Glial Fibrillary Acidic Protein (GFAP) in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Head Trauma", Acad Emerg Med., (20151100), vol. 22, no. 11, doi:10.1111/acem.12795, pages 1274 - 1282, XP071989593
OPPOSITION- Stefania Mondello, Akinyi Linnet, Andras Buki, Steven Robicsek, Andrea Gabrielli, Joseph Tepas, Linda Papa, Gretchen M Brophy, Frank Tortella, Ronald L Hayes, Kevin K Wang, "Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury", Neurosurgery, United States, United States , doi:10.1227/NEU.0b013e318236a809, (20120301), pages 666 - 675, Neurosurgery, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288385/pdf/nihms330663.pdf, XP055438533
OPPOSITION- Amundson Beret E., Apple Fred S., "Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction", Clinical Chemistry and Laboratory Medicine (CCLM), De Gruyter, Berlin, Berlin, (20150101), vol. 53, no. 5, doi:10.1515/cclm-2014-0837, ISSN 1434-6621, XP093308775
OPPOSITION- Larsson Anders, Greig-Pylypczuk Roman, Huisman Albert, "The state of point-of-care testing: a european perspective", UPSALA JOURNAL OF MEDICAL SCIENCES., UPSALA MEDICAL SOCIETY., SE, SE , (20150102), vol. 120, no. 1, doi:10.3109/03009734.2015.1006347, ISSN 0300-9734, pages 1 - 10, XP093308766

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents